Association between cognitive impairment and cardiovascular burden in patients with severe mental disorder

References

• An, J., Li, H., Tang, Z., Zheng, D., Guo, J., Liu, Y., … Luo, Y. (2018). Cognitive impairment and risk of all-cause and cardiovascular disease mortality over 20-year follow-up: Results from the BLSA. Journal of the American Heart Association, 7(15), e008252. doi: 10.1161/JAHA.117.008252
   PubMed Web of Science ®Google Scholar
• Badia, X., Schiaffino, A., Alonso, A., & Herdman, M. (1998). Using the EuroQoL 5-D in the Catalan general population: Feasibility and construct validity. Quality of Life Research, 7, 311–322. doi: 10.1023/A:1008894502042
   PubMed Web of Science ®Google Scholar
• Bennett, S., & Thomas, A. J. (2014). Depression and dementia: Cause, consequence or coincidence? Maturitas, 79(2), 184–190. doi: 10.1016/j.maturitas.2014.05.009
   PubMed Web of Science ®Google Scholar
• Berrocal Izquierdo, N. (2017). Frecuencia y factores de riesgo de enfermedad cerebrovascular en esquizofrenia y trastornos relacionados (Tesis doctoral). Barcelona, Universitat de Barcelona.
   Google Scholar
• Bolandzadeh, N., Davis, J. C., Tam, R., Handy, T. C., & Liu-Ambrose, T. (2012). The association between cognitive function and white matter lesion location in older adults: A systematic review. BMC Neurology, 12, 126. doi: 10.1186/1471-2377-12-126
   PubMed Web of Science ®Google Scholar
• Cai, L., & Huang, J. (2018). Schizophrenia and risk of dementia: A meta-analysis study. Neuropsychiatric Disease and Treatment, 14, 2047–2055. doi: 10.2147/NDT.S172933
   PubMed Web of Science ®Google Scholar
• Chakrabarty, T., Hadjipavlou, G., & Lam, R. W. (2016). Cognitive dysfunction in major depressive disorder: Assessment, impact, and management. Focus, 14, 194–206. doi: 10.1176/appi.focus.20150043
   PubMedGoogle Scholar
• Clerici, F., Caracciolo, B., Cova, I., Fusari Imperatori, S., Maggiore, L., Galimberti, D., … Fratiglioni, L. (2012). Does vascular burden contribute to the progression of mild cognitive impairment to dementia? Dementia and Geriatric Cognitive Disorders, 34, 235–243. doi: 10.1159/000343776
   PubMed Web of Science ®Google Scholar
• Colom, F., Vieta, E., Martínez-Arán, A., García-García, M., Reinares, M., Torrent, C., … Salamero, M. (2002). Versión española de una escala de evaluación de la manía: validez y fiabilidad de la Escala de Young. Medicina Clínica, 119, 366–371. doi: 10.1016/S0025-7753(02)73419-2
   PubMed Web of Science ®Google Scholar
• Diniz, B. S., Teixeira, A. L., Cao, F., Gildengers, A., Soares, J. C., Butters, M. A., & Reynolds, C. F. (2017). History of bipolar disorder and the risk of dementia: A systematic review and meta-analysis. The American Journal of Geriatric Psychiatry, 25(4), 357–362. doi: 10.1016/j.jagp.2016.11.014
   PubMed Web of Science ®Google Scholar
• Ebaid, D., Crewther, S. G., MacCalman, K., Brown, A., & Crewther, D. P. (2017). Cognitive processing speed across the lifespan: Beyond the influence of motor speed. Frontiers in Aging Neuroscience, 9, 62. doi: 10.3389/fnagi.2017.00062
   PubMed Web of Science ®Google Scholar
• Foguet-Boreu, Q., Fernandez San Martin, M. I., Flores Mateo, G., Zabaleta Del Olmo, E., Ayerbe García-Morzon, L., Perez-Piñar López, M., … Violán, C. (2016). Cardiovascular risk assessment in patients with a severe mental illness: A systematic review and meta-analysis. BMC Psychiatry, 16, 141. doi: 10.1186/s12888-016-0833-6
   PubMed Web of Science ®Google Scholar
• Fuhrmann, D., Nesbitt, D., Shafto, M., Rowe, J. B., Price, D., Gadie, A., … Villis, L. (2019). Strong and specific associations between cardiovascular risk factors and white matter micro- and macrostructure in healthy aging. Neurobiology of Aging, 74, 46–55. doi: 10.1016/j.neurobiolaging.2018.10.005
   PubMed Web of Science ®Google Scholar
• Green, M. F., & Harvey, P. D. (2014). Cognition in schizophrenia: Past, present and future. Schizophrenia Research: Cognition, 1(1), e1–e9. doi: 10.1016/j.scog.2014.02.001
   PubMedGoogle Scholar
• Kanuch, S. W., Cassidy, K. A., Dawson, N. V., Athey, M., Fuentes-Casiano, E., & Sajatovic, M. (2016). Recruiting and retaining individuals with serious mental illness and diabetes in clinical research: Lessons learned from a randomized, controlled trial. Journal of Health Disparities Research and Practice, 9(3), 115–126.
   PubMedGoogle Scholar
• Kim, E. J., Bahk, Y. C., Oh, H., Lee, W. H., Lee, J. S., & Choi, K. H. (2018). Current status of cognitive remediation for psychiatric disorders: A review. Frontiers in Psychiatry, 9, 461. doi: 10.3389/fpsyt.2018.00461
   PubMed Web of Science ®Google Scholar
• Lepage, M., Bodnar, M., & Bowie, C. R. (2014). Neurocognition: Clinical and functional outcomes in schizophrenia. The Canadian Journal of Psychiatry, 59(1), 5–12. doi: 10.1177/070674371405900103
   PubMed Web of Science ®Google Scholar
• Lo, R. Y., Jagust, W. J., & Alzheimer’s Disease Neuroimaging Initiative. (2012). Vascular burden and Alzheimer disease pathologic progression. Neurology, 79(13), 1349–1355. doi: 10.1212/WNL.0b013e31826c1b9d
   PubMed Web of Science ®Google Scholar
• Lobo, A., Chamorro, L., Luque, A., Dal-Ré, R., Badia, X., & Baró, E. (2002). Validación de las versiones en español de la Montgomery-Asberg Depression Rating Scale y la Hamilton Anxiety Rating Scale para la evaluación de la depresión y de la ansiedad. Medicina Clínica, 118, 493–499. doi: 10.1016/S0025-7753(02)72429-9
   PubMed Web of Science ®Google Scholar
• Marrugat, J., Solanas, P., D’Agostino, R., Sullivan, L., Ordovas, J., Cordon, F., … Kannel, W. B. (2003). Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Revista Española de Cardiología, 56, 253–261. doi: 10.1016/S0300-8932(03)76861-4
   PubMed Web of Science ®Google Scholar
• Millan, M. J., Agid, Y., Brüne, M., Bullmore, E. T., Carter, C. S., Clayton, N. S., … Young, L. J. (2012). Cognitive dysfunction in psychiatric disorders: Characteristics, causes and the quest for improved therapy. Nature Reviews Drug Discovery, 11(2), 141–168. doi: 10.1038/nrd3628
   PubMed Web of Science ®Google Scholar
• Ming, L., & Spaulding, W. D. (2016). The neuropsychopathology of schizophrenia. Molecules, brain systems, motivation and cognition (1st ed.). Lincoln, NE: Springer.
   Google Scholar
• Ministry of Health and Social Policy. (2009). Guideline development group of the clinical practice guideline on psychosocial interventions in severe mental illness. Clinical Practice Guideline for Psychosocial Interventions in Severe Mental Illness. Quality Plan for the National Health System, Ministry of Health and Social Policy, Aragon Health Sciences Institute – I + CS; 2009. Clinical Practice Guidelines in the Spanish NHS: IC + CS No 2007/05.
   Google Scholar
• Osborn, D. P., Hardoon, S., Omar, R. Z., Holt, R. I., King, M., Larsen, J., … Petersen, I. (2015). Cardiovascular risk prediction models for people with severe mental illness: Results from the prediction and management of cardiovascular risk in people with severe mental illnesses (PRIMROSE) research program. JAMA Psychiatry, 72(2), 143–151. doi: 10.1001/jamapsychiatry.2014.2133
   PubMed Web of Science ®Google Scholar
• Osborn, D. P., Wright, C. A., Levy, G., King, M. B., Deo, R., & Nazareth, I. (2008). Relative risk of diabetes, dyslipidaemia, hypertension and the metabolic syndrome in people with severe mental illnesses: Systematic review and meta-analysis. BMC Psychiatry, 8, 84. doi: 10.1186/1471-244X-8-84
   PubMed Web of Science ®Google Scholar
• Overall, J. E., & Gorham, D. R. (1962). The brief psychiatric rating scale. Psychological Reports, 10, 799–812. doi: 10.2466/pr0.1962.10.3.799
   Web of Science ®Google Scholar
• Pérez-Piñar, M., Mathur, R., Foguet, Q., Ayis, S., Robson, J., & Ayerbe, L. (2016). Cardiovascular risk factors among patients with schizophrenia, bipolar, depressive, anxiety, and personality disorders. European Psychiatry, 35, 8–15. doi: 10.1016/j.eurpsy.2016.02.004
   PubMed Web of Science ®Google Scholar
• Peters, R., Booth, A., Rockwood, K., Peters, J., D'Este, C., & Anstey, K. J. (2019). Combining modifiable risk factors and risk of dementia: A systematic review and meta-analysis. BMJ Open, 9(1), e022846. doi: 10.1136/bmjopen-2018-022846
   PubMed Web of Science ®Google Scholar
• Pino, O., Guilera, G., Rojo, J. E., Gómez-Benito, J., & Purdon, S. E. (2014). SCIP-S, Screening del Deterioro Cognitivo en Psiquiatría. Madrid: TEA Ediciones.
   Google Scholar
• Purdon, S. E. (2005). Screen for cognitive impairment in Psychiatry (SCIP): Administration Manual and norms. Edmonton: PNL.
   Google Scholar
• Rosa, A. R., Sánchez-Moreno, J., Martínez-Aran, A., Salamero, M., Torrent, C., Reinares, M., … Vieta, E. (2007). Validity and reliability of the functioning assessment short test (FAST) in bipolar disorder. Clinical Practice & Epidemiology in Mental Health, 3, 5. doi: 10.1186/1745-0179-3-5
   PubMedGoogle Scholar
• Samuel, R., Thomas, E., & Jacob, K. S. (2018). Instrumental activities of daily living dysfunction among people with schizophrenia. Indian Journal of Psychological Medicine, 40(2), 134–138.
   PubMedGoogle Scholar
• Storch Jakobsen, A., Speyer, H., Nørgaard, H. C. B., Hjorthøj, C., Krogh, J., Mors, O., & Nordentoft, M. (2018). Associations between clinical and psychosocial factors and metabolic and cardiovascular risk factors in overweight patients with schizophrenia spectrum disorders – Baseline and two-years findings from the CHANGE trial. Schizophrenia Research, 199, 96–102. doi: 10.1016/j.schres.2018.02.047
   PubMed Web of Science ®Google Scholar
• Vancampfort, D., Correll, C. U., Galling, B., Probst, M., De Hert, M., Ward, P. B., … Stubbs, B. (2016). Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: A systematic review and large scale meta-analysis. World Psychiatry, 15(2), 166–174. doi: 10.1002/wps.20309
   PubMed Web of Science ®Google Scholar
• Vancampfort, D., Stubbs, B., Mitchell, A. J., De Hert, M., Wampers, M., Ward, P. B., … Correll, C. U. (2015). Risk of metabolic syndrome and its components in people with schizophrenia and related psychotic disorders, bipolar disorder and major depressive disorder: A systematic review and meta-analysis. World Psychiatry, 14(3), 339–347. doi: 10.1002/wps.20252
   PubMed Web of Science ®Google Scholar
• Ward, K. M., Kraal, A. Z., Flowers, S. A., & Ellingrod, V. L. (2017). Cardiovascular pharmacogenomics and cognitive function in patients with schizophrenia. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 37(9), 1122–1130. doi: 10.1002/phar.1968
   Google Scholar
• Zomer, E., Osborn, D., Nazareth, I., Blackburn, R., Burton, A., Hardoon, S., … Hunter, R. M. (2017). Effectiveness and cost-effectiveness of a cardiovascular risk prediction algorithm for people with severe mental illness (PRIMROSE). BMJ Open, 7(9), e018181. doi: 10.1136/bmjopen-2017-018181
   PubMed Web of Science ®Google Scholar